Cedars-Sinai Cardiomyopathy Expert Available to Comment on Treatments
Cedars-Sinai
Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that Health Canada has approved the CardioFlux Magnetocardiograph with a license for use by physicians to aid in the diagnosis of myocardial ischemia.
Living among nature and in close proximity to rivers were linked with better heart health; however, study results also show that environmental and social factors associated with inner-city living can outweigh benefits of park proximity for residents living in disadvantaged neighborhoods.
Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease and stroke, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Hackensack Meridian Mountainside Medical Center is honored to announce its selection as a site for the groundbreaking STEMI-DTU Clinical Trial.
Cardiovascular health behaviors and overall cardiovascular health were directly associated with adolescent brain development and cognitive function, according to UTHealth Houston research published recently in the journal Mental Health and Physical Activity.
Mount Sinai study could lead to new treatments for fibromuscular dysplasia
Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the high-fat, high-energy diet of their mother.
A UCLA-led study involving mice and human data could also have implications for individuals with diabetes and obesity, uncovering new treatment possibilities for life-threatening arrhythmias.
UNC School of Medicine researchers are the first to show that an microRNA molecule called miR-29 is instrumental in driving the natural aging process.
Mountainside is a site for the Genetesis MICRO 2.0 Clinical Trial, advancing non-invasive cardiac diagnostics to evaluate coronary microvascular dysfunction. This study explores how magnetocardiography could revolutionize heart condition diagnosis and management.
Physical human feats require a high level of coordination between the sensory functions of our skin and motor functions of our muscles. What kind of achievements could robots perform with the same cohesion between sensing and action? In the medical space, researchers have begun to explore the possibilities.
Blocking oxidative stress enzyme prevents, even reverses, heart condition in lab models
Heart failure during pregnancy is a dangerous and often under-detected condition because common symptoms – shortness of breath, extreme fatigue and trouble breathing while lying down – are easily mistaken for typical pregnancy discomforts. Late-breaking research presented at the European Society of Cardiology Congress on a Mayo Clinic study showed an artificial intelligence (AI)-enabled digital stethoscope helped doctors identify twice as many cases of heart failure compared to a control group that received usual obstetric care and screening. Full study findings are published in Nature Medicine.
Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified by researchers at UTHealth Houston.
The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.